Given the increased expression of AIB1 protein in cervical cancer cell lines, we investigated the levels of AIB1 during initiation and/or progression of neoplasia in vivo by obtaining clinical samples to perform immunohistochemistry. The gene discussed is NCOA3; the disease is cervical cancer.